Aura Biosciences, Inc.

AURA

Aura Biosciences, Inc.

AURA

Insider Sentiment (TTM):

Last Purchase:2025-05-16Last Sale:2026-06-16Shares Purchased (TTM):0Shares Sold (TTM):7,117,453

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:50,442,813Shares Outstanding:67,447,576Institutional Ownership Pct.:74.79%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Biological Products, (No Diagnostic Substances)

AMGN GILD SCLX BIIB MRNA RVMD

Aura Biosciences, Inc. (AURA) — SEC Financial Statements & Analysis

Aura Biosciences, Inc. (AURA) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	85	60	48	107	38	32	25	30	26	41	56	48
Marketable Securities	30	85	114	70	90	119	149	157	177	185	93	114
Prepaid Expense And Other Assets Current	4	5	8	7	7	10	9	8	9	6	5	4
Restricted Cash And Cash Equivalents At Carrying V…	-	-	-	-	-	0	0	0	0	0	0	0
Assets Current	119	150	170	184	135	161	183	196	212	232	154	166
Restricted Cash And Cash Equivalents Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	15	16	16	17	17	17	18	18	19	19	20	20
Other Assets Noncurrent	1	0	0	0	0	1	0	0	0	1	1	1
Property Plant And Equipment Net	2	3	3	3	3	3	3	3	3	3	5	5
Assets	138	169	190	204	155	183	205	218	235	255	180	193
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	2	2	1	2	2	2	1	2	2	1	1
Operating Lease Liability Current	3	3	3	3	3	3	3	3	3	3	3	3
Liabilities Current	17	18	19	15	12	15	15	11	10	12	11	9
Operating Lease Liability Noncurrent	14	14	15	15	15	16	16	16	17	17	17	17
Liabilities	30	33	33	30	27	31	31	27	26	29	28	26
Stockholders Equity
Additional Paid In Capital	622	617	611	603	530	526	522	519	516	513	417	413
Retained Earnings Accumulated Deficit	-514	-480	-455	-429	-402	-374	-348	-327	-307	-287	-265	-247
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	1	-0	0	1	-0	-0
Stockholders Equity	107	137	157	175	128	152	175	191	209	226	152	166
Liabilities And Stockholders Equity	138	169	190	204	155	183	205	218	235	255	180	193
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	450	450	450	450	450	450	450	450	450	450	450	450
Common Stock Shares Issued	64	64	63	62	50	50	50	50	50	49	38	38
Shares Outstanding	64	64	63	62	50	50	50	50	50	49	38	38

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-19.05%	-5.49%	-	-	-	-	-	-	-	-	-	-
2025	25.48%	26.64%	30.12%	-10.37%	-16.32%	-15.21%	16.27%	-4.16%	1.27%	17.26%	22.58%	2.26%
2024	-2.52%	0.27%	37.40%	-6.14%	6.61%	28.93%	-15.77%	-20.66%	-26.29%	-23.43%	-15.00%	-8.29%
2023	-	-	-	-5.18%	-18.53%	-34.15%	16.52%	26.21%	8.12%	-6.62%	-5.58%	-4.81%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	7.09	8.15	9.04	12.39	11.06	10.77	12.47	18.54	21.97	18.76	14.13	18.69
Quick Ratio	6.87	7.85	8.60	11.94	10.52	10.13	11.85	17.77	20.99	18.30	13.68	18.22
Working Capital	101.80M	131.36M	151.30M	169.11M	122.35M	145.71M	168.77M	185.05M	202.59M	219.44M	142.99M	157.32M
Leverage & Debt
Debt to Equity	0.28	0.24	0.21	0.17	0.21	0.20	0.18	0.14	0.13	0.13	0.18	0.16
Debt Ratio	0.22	0.19	0.18	0.15	0.18	0.17	0.15	0.12	0.11	0.11	0.16	0.14
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.67	-1.76	-1.61	-1.75	-1.89	-1.75	-1.68	-1.63	-1.59	-1.93	-1.86	-1.80
Free Cash Flow Per Share TTM	-1.36	-1.41	-1.35	-1.45	-1.60	-1.63	-1.50	-1.50	-1.47	-1.63	-1.71	-1.60
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	18.69%	22.17%	27.94%	25.65%	20.40%	13.76%	17.48%	18.26%	24.06%	30.03%	3.23%	10.84%
EPS Growth (1Y)	-11.79%	0.53%	-3.64%	7.31%	18.79%	-9.22%	-9.67%	-9.64%	-5.21%	-1.75%	-20.86%	-14.35%
Valuation Metrics
P/E TTM	-4.01	-3.10	-3.83	-3.58	-3.10	-4.70	-5.32	-4.64	-4.94	-4.59	-4.84	-6.85
P/B	4.21	2.40	2.60	2.08	2.30	2.69	2.53	1.96	1.86	1.55	2.26	2.81
Market Cap	451.22M	328.84M	407.49M	363.18M	293.74M	408.13M	442.50M	374.58M	388.20M	351.03M	342.52M	467.52M
Enterprise Value	365.66M	268.56M	359.17M	255.04M	254.75M	376.43M	417.10M	343.74M	361.92M	309.18M	286.94M	419.78M
Calculated Values
Free Cash Flow TTM	-91.64M	-85.19M	-88.80M	-84.22M	-80.06M	-81.06M	-74.51M	-74.39M	-72.58M	-64.56M	-65.22M	-60.55M
Net Debt	-85.56M	-60.28M	-48.32M	-108.14M	-38.99M	-31.69M	-25.41M	-30.84M	-26.28M	-41.85M	-55.58M	-47.73M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-16Sale

Owner: Gibney, Anthony S

Title: See Remarks

Shares: 12,824

Price/Share: $6.42

Value: $82,330.08

Shares Owned: 265,354

Relationship: Officer

Ownership: Direct

2026-05-07Sale

Owner: Matrix, Capital Managemen…

Title: -

Shares: 6,922,870

Price/Share: $5.64

Value: $39,044,986.80

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-16Sale

Owner: Kilroy, Conor

Title: See Remarks

Shares: 11,738

Price/Share: $7.02

Value: $82,400.76

Shares Owned: 217,835

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Kilroy, Conor

Title: See Remarks

Shares: 12,079

Price/Share: $5.05

Value: $60,998.95

Shares Owned: 167,234

Relationship: Officer

Ownership: Direct

2026-02-17Sale

Owner: Hopkins, Janet Jill

Title: Chief Medical Officer

Shares: 20,401

Price/Share: $5.06

Value: $103,229.06

Shares Owned: 232,284

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-16	Gibney, Anthony S	Officer	See Remarks	Direct	Sale	12,824	6.42	$82,330.08	265,354	4
2026-05-07	Matrix, Capital Managemen…	TenPercentOwner	-	Indirect	Sale	6,922,870	5.64	$39,044,986.80	0	4
2026-04-16	Kilroy, Conor	Officer	See Remarks	Direct	Sale	11,738	7.02	$82,400.76	217,835	4
2026-02-17	Kilroy, Conor	Officer	See Remarks	Direct	Sale	12,079	5.05	$60,998.95	167,234	4
2026-02-17	Hopkins, Janet Jill	Officer	Chief Medical Officer	Direct	Sale	20,401	5.06	$103,229.06	232,284	4
2026-02-17	Plavsic, Mark	Officer	Chief Technology Officer	Direct	Sale	15,890	5.05	$80,244.50	181,397	4
2026-02-17	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	8,549	5.06	$43,257.94	75,532	4
2026-02-17	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	47,648	5.06	$241,098.88	409,815	4
2026-01-20	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	16,928	4.86	$82,270.08	457,463	4
2026-01-20	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	1,581	4.86	$7,683.66	84,081	4
2025-11-17	Hopkins, Janet Jill	Officer	Chief Medical Officer	Direct	Sale	17,109	5.42	$92,730.78	252,685	4
2025-10-29	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	9,049	6.35	$57,461.15	474,391	4
2025-10-29	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	896	6.35	$5,689.60	85,662	4
2025-10-16	Plavsic, Mark	Officer	Chief Technology Officer	Direct	Sale	12,169	6.35	$77,273.15	197,287	4
2025-08-18	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	7,722	6.70	$51,737.40	86,558	4
2025-05-16	Gibney, Anthony S	Officer	See Remarks	Direct	Purchase	50,000	4.90	$245,000.00	58,452	4
2025-05-16	Gibney, Anthony S	Officer	See Remarks	Direct	Sale	1,519	5.15	$7,822.85	56,933	4
2025-05-16	Johnson, David Michael	Director	-	Direct	Purchase	20,000	4.90	$98,000.00	166,167	4
2025-04-16	Kilroy, Conor	Officer	See Remarks	Direct	Sale	7,162	5.49	$39,319.38	179,313	4
2025-04-16	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	897	5.49	$4,924.53	81,381	4
2025-02-18	Elazzouzi, Amy	Officer	Senior Vice President, Finance	Direct	Sale	1,404	7.75	$10,881.00	82,278	4
2025-02-18	Hopkins, Janet Jill	Officer	Chief Medical Officer	Direct	Sale	2,534	7.75	$19,638.50	269,794	4
2025-02-18	Plavsic, Mark	Officer	Chief Technology Officer	Direct	Sale	2,151	7.75	$16,670.25	209,456	4
2025-02-18	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	20,221	7.75	$156,712.75	482,440	4
2025-01-21	Elazzouzi, Amy	Officer	Vice President, Finance	Direct	Sale	1,001	7.67	$7,677.67	38,442	4
2025-01-21	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	15,955	7.67	$122,374.85	304,692	4
2024-11-18	Hopkins, Janet Jill	Officer	Chief Medical Officer	Direct	Sale	11,822	9.36	$110,653.92	151,693	4
2024-10-29	Elazzouzi, Amy	Officer	Vice President, Finance	Direct	Sale	553	10.74	$5,939.22	39,443	4
2024-10-29	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	9,200	10.74	$98,808.00	320,647	4
2024-10-18	Feder, Julie B	Officer	Chief Financial Officer	Direct	Sale	25,131	12.03	$302,325.93	134,276	4
2024-10-18	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	24,992	12.04	$300,903.68	329,847	4
2024-10-16	Plavsic, Mark	Officer	Chief Technology Officer	Direct	Sale	7,383	9.85	$72,722.55	121,132	4
2024-01-23	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	15,853	7.64	$121,116.92	161,438	4
2024-01-23	Feder, Julie B	Officer	Chief Financial Officer	Direct	Sale	6,609	7.64	$50,492.76	62,991	4
2023-11-09	Matrix, Capital Managemen…	TenPercentOwner	-	Indirect	Purchase	1,560,000	9.00	$14,040,000.00	6,922,870	4
2023-11-08	Johnson, David Michael	Director	-	Direct	Purchase	9,601	7.30	$70,087.30	135,667	4
2023-11-06	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	7,449	12.03	$89,611.47	177,291	4
2023-11-06	Feder, Julie B	Officer	Chief Financial Officer	Direct	Sale	3,900	12.07	$47,073.00	69,600	4
2023-10-30	De, Los Pinos Elisabet	Director,Officer	See Remarks	Direct	Sale	9,586	6.83	$65,472.38	180,940	4
2023-10-30	Feder, Julie B	Officer	Chief Financial Officer	Direct	Sale	3,385	6.82	$23,085.70	69,600	4
2023-10-04	Johnson, David Michael	Director	-	Direct	Purchase	6,566	8.61	$56,533.26	50,066	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

74.79%

Inst. Shares: 50,442,813

Shares Outstanding: 67,447,576

2025-12-31

82.46%

Inst. Shares: 49,757,291

Shares Outstanding: 60,337,608

2025-09-30

77.51%

Inst. Shares: 51,108,349

Shares Outstanding: 65,936,672

2025-06-30

85.95%

Inst. Shares: 49,863,362

Shares Outstanding: 58,015,718

2025-03-31

78.14%

Inst. Shares: 39,168,120

Shares Outstanding: 50,126,148

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	50,442,813	67,447,576	74.79%
2025-12-31	49,757,291	60,337,608	82.46%
2025-09-30	51,108,349	65,936,672	77.51%
2025-06-30	49,863,362	58,015,718	85.95%
2025-03-31	39,168,120	50,126,148	78.14%
2024-12-31	38,740,410	49,650,480	78.03%
2024-09-30	36,210,519	49,663,532	72.91%
2024-06-30	38,998,070	49,548,120	78.71%
2024-03-31	38,379,177	49,451,943	77.61%
2023-12-31	36,245,515	39,620,036	91.48%
2023-09-30	26,749,542	38,185,197	70.05%
2023-06-30	26,325,834	37,855,533	69.54%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Aura Biosciences, Inc. (AURA) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.